During the past decade, Sezione di Ematologia ed Immunologia Clinica - Ospedale S.Maria della Misericordia conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 1 clinical trials were completed, i.e. on average, 4.3% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sezione di Ematologia ed Immunologia Clinica - Ospedale S.Maria della Misericordia" #1 sponsor was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 22 trials, followed by "Fondazione Italiana Linfomi ONLUS" with 4 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Incyte Corporation" with 1 trials sponsored and "Tiziana Marangon" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sezione di Ematologia ed Immunologia Clinica - Ospedale S.Maria della Misericordia" #1 collaborator was "Janssen-Cilag S.p.A." with 1 trials as a collaborator, "Roche Pharma AG" with 1 trials as a collaborator and "Study Alliance Leukemia (SAL) Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Sezione di Ematologia ed Immunologia Clinica - Ospedale S.Maria della Misericordia" are "Acute Myeloid Leukemia" (6 trials), "Acute Lymphoblastic Leukemia" (3 trials), "Acute Promyelocytic Leukemia" (2 trials), "Chronic Lymphocytic Leukemia" (2 trials) and "Leukemia" (2 trials). Many other conditions were trialed in "Sezione di Ematologia ed Immunologia Clinica - Ospedale S.Maria della Misericordia" in a lesser frequency.

Most popular intervention types in "Sezione di Ematologia ed Immunologia Clinica - Ospedale S.Maria della Misericordia" are "Drug" (22 trials), "Other" (4 trials), "Combination Product" (1 trials), "Genetic" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ibrutinib" (3 trials), "Ponatinib" (2 trials), "Rituximab" (2 trials), "Venetoclax" (2 trials) and "all-trans retinoic acid (ATRA)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sezione di Ematologia ed Immunologia Clinica - Ospedale S.Maria della Misericordia" are 29 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Sezione di Ematologia ed Immunologia Clinica - Ospedale S.Maria della Misericordia". 1 are not yet recruiting, 10 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Sezione di Ematologia ed Immunologia Clinica - Ospedale S.Maria della Misericordia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Sezione di Ematologia ed Immunologia Clinica - Ospedale S.Maria della Misericordia, 1 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".